RETRACTED: No deleterious effect of lockdown due to COVID-19 pandemic on glycaemic control, measured by glucose monitoring, in adults with type 1 diabetes.

The Editor of Diabetes Technology & Therapeutics is officially retracting the article entitled, "No Deleterious Effect of Lockdown Due to COVID-19 Pandemic on Glycaemic Control, Measured by Glucose Monitoring, in Adults with Type 1 Diabetes," by Beato-Vibora PI. Diabetes Technol Ther 2020; epub DOI: 10.1089/dia.2020.0184. After the Instant Online publication of the article, the journal editor received correspondence indicating that some portions of the paper may have been plagiarized. An internal investigation was launched into the accusation, and though the charge of plagiarism was not found to be compelling, it was discovered that the author's Institutional Review Board approval statements for the paper were secured after submission and publication of the article, and only after the publisher requested said documentation. The author explained that IRB approval was not secured due to her institution's closure because of the COVID-19 pandemic. Despite these unusual circumstances, it is a clear violation of proper and standard protocols for studies containing human subjects, and therefore the Journal officially retracts the paper. Diabetes Technology & Therapeutics, its editors, and its publisher are committed to upholding the strictest standards of the scientific record and the community it serves and will not tolerate any improprieties or violations of proper scientific publishing conventions.